Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

244 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Uncovering the interplay between CD8, CD4 and antibody responses to complex pathogens.
Moutaftsi M, Tscharke DC, Vaughan K, Koelle DM, Stern L, Calvo-Calle M, Ennis F, Terajima M, Sutter G, Crotty S, Drexler I, Franchini G, Yewdell JW, Head SR, Blum J, Peters B, Sette A. Moutaftsi M, et al. Among authors: sutter g. Future Microbiol. 2010 Feb;5(2):221-39. doi: 10.2217/fmb.09.110. Future Microbiol. 2010. PMID: 20143946 Free PMC article. Review.
Myxoma virus leukemia-associated protein is responsible for major histocompatibility complex class I and Fas-CD95 down-regulation and defines scrapins, a new group of surface cellular receptor abductor proteins.
Guerin JL, Gelfi J, Boullier S, Delverdier M, Bellanger FA, Bertagnoli S, Drexler I, Sutter G, Messud-Petit F. Guerin JL, et al. Among authors: sutter g. J Virol. 2002 Mar;76(6):2912-23. doi: 10.1128/jvi.76.6.2912-2923.2002. J Virol. 2002. PMID: 11861858 Free PMC article.
Construction and isolation of recombinant MVA.
Staib C, Drexler I, Sutter G. Staib C, et al. Among authors: sutter g. Methods Mol Biol. 2004;269:77-100. doi: 10.1385/1-59259-789-0:077. Methods Mol Biol. 2004. PMID: 15114009 Review.
A phase I vaccination study with tyrosinase in patients with stage II melanoma using recombinant modified vaccinia virus Ankara (MVA-hTyr).
Meyer RG, Britten CM, Siepmann U, Petzold B, Sagban TA, Lehr HA, Weigle B, Schmitz M, Mateo L, Schmidt B, Bernhard H, Jakob T, Hein R, Schuler G, Schuler-Thurner B, Wagner SN, Drexler I, Sutter G, Arndtz N, Chaplin P, Metz J, Enk A, Huber C, Wölfel T. Meyer RG, et al. Among authors: sutter g. Cancer Immunol Immunother. 2005 May;54(5):453-67. doi: 10.1007/s00262-004-0616-7. Epub 2004 Dec 31. Cancer Immunol Immunother. 2005. PMID: 15627214 Free PMC article. Clinical Trial.
244 results